Company: INVUP
Filing Date: 2025-03-28
Form Type: 10-K
Source: 0001641172-25-001193
Chunk: 232

Company: Investview, Inc.
Filing Date: 2025-03-28
Form: 10-K
Item: Item 8
Chunk 232
---
-use assets obtained in exchange for new operating lease liabilities amounted to $23,520.

At
date of acquisition of the Haverford Lease, right-of-use assets and lease liabilities obtained amounted to $125,522 and $152,961, respectively.
The term of the Haverford Lease was initially extended through December 2024. At the extension of the Haverford Lease, right-of-use assets
obtained in exchange for new operating lease liabilities amounted to $172,042. On August 7, 2024, the term of the Haverford Lease was
extended through December 31, 2025.

At
commencement of the Warminster Lease, right-of-use assets obtained in exchange for new operating lease liabilities amounted to $108,327.
The Warminster Lease will automatically terminate after the 14-month term.

At
commencement of the Ivyland Lease, right-of-use assets obtained in exchange for new operating lease liabilities amounted to $115,037.
The Ivyland Lease will automatically terminate after the 24-month term.

Operating
lease expense was $130,710 for the year ended December 31, 2024. Operating cash flows used for the operating leases during the year ended
December 31, 2024, was $135,809. As of December 31, 2024, the weighted average remaining lease term was 1.48 years, and the weighted average
discount rate was 12%.

Future
minimum lease payments under non-cancellable leases as of December 31, 2024, were as follows:

 SCHEDULE OF FUTURE MINIMUM LEASE PAYMENTS UNDER NON-CANCELLABLE LEASES

    2025 
    $171,148 
  
    2026 
     61,057 
  
    Total 
     232,205 
  
    Less:
    Interest 
     (20,065)
  
    Present value of lease
    liability 
     212,140 
  
    Operating
    lease liability, current [1] 
     (165,707)
  
    Operating
    lease liability, long term 
    $46,433 

    [1]
    Represents
    lease payments to be made in the next 12 months.

NOTE
9 – STOCKHOLDERS’ EQUITY

Preferred
Stock

We
are authorized to issue up to 50,000,000 shares of preferred stock with a par value of $0.001 and our